Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Evotec AG

Start price
Target price
Perf. (%)
€23.21
15.06.22
-
15.06.23
4.09%
01.07.22

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€18.69
12.06.22
-
12.06.23
4.52%
01.07.22

Could be worthwhile Investment >10% per year
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€3.34
22.05.22
-
22.05.23
-19.27%
01.07.22

buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€41.80
12.05.22
-
12.05.23
-2.27%
01.07.22

buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€48.92
25.04.22
€120.00
03.02.25
-23.06%
01.07.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue growth >5% per year expected
High valuation
buy
Paul Hartmann AG

Start price
Target price
Perf. (%)
€326.00
04.04.22
-
04.04.23
-1.23%
01.07.22

buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.14
26.02.22
-
26.02.23
-34.78%
01.07.22

Could be very worthwhile Investment >20% year
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.79
22.02.22
€4.00
22.02.23
-40.03%
01.07.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Medigene AG

Start price
Target price
Perf. (%)
€2.91
21.02.22
-
21.02.29
-21.99%
01.07.22

Probably not worthwhile Investment
buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€147.00
01.02.22
€180.00
01.08.22
-20.17%
01.07.22

Could be very worthwhile Investment >20% year
Standard Investments for future growth
buy
MagForce AG

Start price
Target price
Perf. (%)
€2.37
29.01.22
€2.80
29.01.23
-23.21%
01.07.22

Could be worthwhile Investment >10% per year
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.70
27.01.22
€42.00
27.07.22
-17.37%
01.07.22

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
buy
Bayer AG

Start price
Target price
Perf. (%)
€50.08
24.01.22
-
24.01.26
19.50%
01.07.22

Could be worthwhile Investment >10% per year
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€90.00
12.01.22
-
12.01.23
-58.18%
01.07.22

buy
Nanorepro AG

Start price
Target price
Perf. (%)
€6.38
10.01.22
€7.50
10.01.23
-41.22%
01.07.22

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€30.80
08.01.22
-
08.01.26
-36.57%
01.07.22

Could be worthwhile Investment >10% per year
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€98.65
04.01.22
-
04.01.23
-61.84%
01.07.22

buy
Paion AG

Start price
Target price
Perf. (%)
€1.23
27.12.21
€2.00
27.12.22
-27.24%
01.07.22

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
buy
Stratec SE

Start price
Target price
Perf. (%)
€132.00
23.12.21
-
23.12.22
-32.95%
01.07.22

buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€4.97
23.12.21
-
23.12.22
-8.16%
01.07.22

buy
Mevis Medical Sol.na

Start price
Target price
Perf. (%)
€30.80
23.12.21
-
23.12.22
7.14%
30.06.22

buy
Sartorius AG

Start price
Target price
Perf. (%)
€484.00
23.12.21
-
23.12.22
-31.25%
01.07.22

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€33.28
23.12.21
-
23.12.22
-41.30%
01.07.22

buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.56
23.12.21
-
23.12.22
-26.92%
01.07.22

buy
Maternus-Kliniken AG

Start price
Target price
Perf. (%)
€4.74
23.12.21
-
23.12.22
-39.66%
27.06.22